PRESTIGE CONSUMER HEALTHCARE INC. Cash and Cash Equivalents, Period Increase (Decrease)
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$7.88 million for the 9-month period ending 2018-12-31, per its 10-Q filed 2019-02-07.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-02-07
- PRESTIGE CONSUMER HEALTHCARE INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$12.24M, a 610.13% decline year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was $2.64M.
- PRESTIGE CONSUMER HEALTHCARE INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was $1.72M, a 24.52% decline year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was -$12.83M.
- PRESTIGE CONSUMER HEALTHCARE INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$9.31M, a 163.64% decline from fiscal 2017.
- PRESTIGE CONSUMER HEALTHCARE INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $14.63M, a 147.38% increase from fiscal 2016.
- PRESTIGE CONSUMER HEALTHCARE INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $5.91M.
- PRESTIGE CONSUMER HEALTHCARE INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$7.01M, a 155.39% decline from fiscal 2014.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$12.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-07 | -$9.60M derived: sum of 2 quarters · filed 2019-02-07 | -$7.88M 10-Q · filed 2019-02-07 | -$20.70M derived: sum of 4 quarters · filed 2019-02-07 |
| 2018-09-30 | $2.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-01 | $4.36M 10-Q · filed 2018-11-01 | -$8.47M derived: sum of 3 quarters · filed 2018-11-01 | -$6.07M derived: sum of 4 quarters · filed 2019-02-07 |
| 2018-06-30 | $1.72M 10-Q · filed 2018-08-02 | -$11.11M derived: sum of 2 quarters · filed 2018-08-02 | -$8.71M derived: sum of 3 quarters · filed 2019-02-07 | -$9.87M derived: sum of 4 quarters · filed 2019-02-07 |
| 2018-03-31 | -$12.83M derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-10 | -$10.43M derived: sum of 2 quarters · filed 2019-02-07 | -$11.59M derived: sum of 3 quarters · filed 2019-02-07 | -$9.31M 10-K · filed 2018-05-10 |
| 2017-12-31 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-07 | $1.24M derived: sum of 2 quarters · filed 2019-02-07 | $3.52M 10-Q · filed 2019-02-07 | -$17.91M derived: sum of 4 quarters · filed 2019-02-07 |
| 2017-09-30 | -$1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-01 | $1.12M 10-Q · filed 2018-11-01 | -$20.31M derived: sum of 3 quarters · filed 2018-11-01 | $12.52M derived: sum of 4 quarters · filed 2018-11-01 |
| 2017-06-30 | $2.28M 10-Q · filed 2018-08-02 | -$19.15M derived: sum of 2 quarters · filed 2018-08-02 | $13.68M derived: sum of 3 quarters · filed 2018-08-02 | $15.26M derived: sum of 4 quarters · filed 2018-08-02 |
| 2017-03-31 | -$21.43M derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-10 | $11.40M derived: sum of 2 quarters · filed 2018-05-10 | $12.98M derived: sum of 3 quarters · filed 2018-05-10 | $14.63M 10-K · filed 2018-05-10 |
| 2016-12-31 | $32.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-01 | $34.41M derived: sum of 2 quarters · filed 2018-02-01 | $36.06M 10-Q · filed 2018-02-01 | $14.32M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-09-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-02 | $3.23M 10-Q · filed 2017-11-02 | -$18.52M derived: sum of 3 quarters · filed 2018-05-10 | $8.31M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-06-30 | $1.65M 10-Q · filed 2017-08-03 | -$20.10M derived: sum of 2 quarters · filed 2018-05-10 | $6.72M derived: sum of 3 quarters · filed 2018-05-10 | $7.28M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-03-31 | -$21.74M derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-10 | $5.08M derived: sum of 2 quarters · filed 2018-05-10 | $5.63M derived: sum of 3 quarters · filed 2018-05-10 | $5.91M 10-K · filed 2018-05-10 |
| 2015-12-31 | $26.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-02 | $27.38M derived: sum of 2 quarters · filed 2017-02-02 | $27.66M 10-Q · filed 2017-02-02 | $27.02M derived: sum of 4 quarters · filed 2017-05-17 |
| 2015-09-30 | $554.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-03 | $834.00K 10-Q · filed 2016-11-03 | $201.00K derived: sum of 3 quarters · filed 2017-05-17 | $404.00K derived: sum of 4 quarters · filed 2017-05-17 |
| 2015-06-30 | $280.00K 10-Q · filed 2016-08-04 | -$353.00K derived: sum of 2 quarters · filed 2017-05-17 | -$150.00K derived: sum of 3 quarters · filed 2017-05-17 | $5.92M derived: sum of 4 quarters · filed 2017-05-17 |
| 2015-03-31 | -$633.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-17 | -$430.00K derived: sum of 2 quarters · filed 2017-05-17 | $5.64M derived: sum of 3 quarters · filed 2017-05-17 | -$7.01M 10-K · filed 2017-05-17 |
| 2014-12-31 | $203.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-04 | $6.28M derived: sum of 2 quarters · filed 2016-02-04 | -$6.38M 10-Q · filed 2016-02-04 | -$72.40M derived: sum of 4 quarters · filed 2016-05-17 |
| 2014-09-30 | $6.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-05 | -$6.58M 10-Q · filed 2015-11-05 | -$72.61M derived: sum of 3 quarters · filed 2016-05-17 | -$5.08M derived: sum of 4 quarters · filed 2016-05-17 |
| 2014-06-30 | -$12.66M 10-Q · filed 2015-08-06 | -$78.68M derived: sum of 2 quarters · filed 2016-05-17 | -$11.16M derived: sum of 3 quarters · filed 2016-05-17 | -$3.63M derived: sum of 4 quarters · filed 2016-05-17 |
| 2014-03-31 | -$66.02M derived: 10-K 12 month − 10-Q 9 month · filed 2016-05-17 | $1.50M derived: sum of 2 quarters · filed 2016-05-17 | $9.03M derived: sum of 3 quarters · filed 2016-05-17 | $12.66M 10-K · filed 2016-05-17 |
| 2013-12-31 | $67.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-05 | $75.05M derived: sum of 2 quarters · filed 2015-02-05 | $78.68M 10-Q · filed 2015-02-05 | $83.92M derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-09-30 | $7.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-06 | $11.16M 10-Q · filed 2014-11-06 | $16.40M derived: sum of 3 quarters · filed 2015-05-14 | -$2.17M derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-06-30 | $3.64M 10-Q · filed 2014-08-07 | $8.88M derived: sum of 2 quarters · filed 2015-05-14 | -$9.70M derived: sum of 3 quarters · filed 2015-05-14 | $14.90M derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-03-31 | $5.24M derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-14 | -$13.34M derived: sum of 2 quarters · filed 2015-05-14 | $11.27M derived: sum of 3 quarters · filed 2015-05-14 | -$3.35M 10-K · filed 2015-05-14 |
| 2012-12-31 | -$18.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-07 | $6.03M derived: sum of 2 quarters · filed 2014-02-07 | -$8.58M 10-Q · filed 2014-02-07 | $5.99M derived: sum of 4 quarters · filed 2014-05-19 |
| 2012-09-30 | $24.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-07 | $9.99M 10-Q · filed 2013-11-07 | $24.57M derived: sum of 3 quarters · filed 2014-05-19 | $21.05M derived: sum of 4 quarters · filed 2014-05-19 |
| 2012-06-30 | -$14.61M 10-Q · filed 2013-08-01 | -$35.00K derived: sum of 2 quarters · filed 2014-05-19 | -$3.56M derived: sum of 3 quarters · filed 2014-05-19 | -$1.59M derived: sum of 4 quarters · filed 2014-05-19 |
| 2012-03-31 | $14.58M derived: 10-K 12 month − 10-Q 9 month · filed 2014-05-19 | $11.05M derived: sum of 2 quarters · filed 2014-05-19 | $13.02M derived: sum of 3 quarters · filed 2014-05-19 | $5.68M 10-K · filed 2014-05-19 |
| 2011-12-31 | -$3.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-07 | -$1.55M derived: sum of 2 quarters · filed 2013-02-07 | -$8.89M 10-Q · filed 2013-02-07 | -$78.83M derived: sum of 4 quarters · filed 2013-05-17 |
| 2011-09-30 | $1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-07 | -$5.37M 10-Q · filed 2012-11-07 | -$75.31M derived: sum of 3 quarters · filed 2013-05-17 | -$47.07M derived: sum of 4 quarters · filed 2013-05-17 |
| 2011-06-30 | -$7.34M 10-Q · filed 2012-08-09 | -$77.28M derived: sum of 2 quarters · filed 2013-05-17 | -$49.04M derived: sum of 3 quarters · filed 2013-05-17 | -$27.11M derived: sum of 4 quarters · filed 2013-05-17 |
| 2011-03-31 | -$69.93M derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-17 | -$41.70M derived: sum of 2 quarters · filed 2013-05-17 | -$19.77M derived: sum of 3 quarters · filed 2013-05-17 | -$27.76M 10-K · filed 2013-05-17 |
| 2010-12-31 | $28.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-09 | $50.16M derived: sum of 2 quarters · filed 2012-02-09 | $42.17M 10-Q · filed 2012-02-09 | |
| 2010-09-30 | $21.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-09 | $13.94M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$7.99M 10-Q · filed 2011-08-05 | |||
| 2010-03-31 | $5.92M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |